Category: 1

ABcann Granted Australian Import License

SHARE THIS POST NAPANEE, ON, January 18, 2018 (GLOBE NEWSWIRE) – ABCANN GLOBAL CORPORATION (TSXV: ABCN) (“ABcann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd. (“ABcann Australia”), has received an import license from the Federal Office of Drug Control in Australia. ABcann continues to work with government and its industry partners in Australia to develop exclusive programs targeting physician networks. Following receipt of any necessary approvals, including the approval of the TSX Venture Exchange, ABcann intends to supply medicinal cannabis to the Australian market via the Australian Department of Health’s TGA (Therapeutic Goods Administration) Special Access Scheme. “This import license is a key milestone towards generating revenue through ABcann’s network of physicians, pharmacists and patients, and advancing the use of medical cannabis,” commented Barry Fishman, Chief Executive Officer of ABcann. “We view Australia as an important emerging market for medical cannabis and I look forward to meeting with our strategic partners and stakeholders in Australia later this month to further discuss opportunities there.” “Attainment of this license is one of several important steps we have taken over the last six months to cement key relationships with strategic partners in industry and government. ABcann Australia is committed to providing Australian patients with high quality medicinal cannabis products,” said Henry Pinskier, MD, Chairman of ABcann Australia. About ABcann: ABcann holds production and sales licenses...

Read More

01-18-2018 Video News – The Marijuana Times Show

Joe Klare discusses a new poll about how Americans feel about a possible cannabis crackdown from the feds, what the Attorney General of Colorado thinks about a possible crackdown and whether or not Los Angeles has finally got its regulatory act together. 01-18-2018 – Ep. 54 | Marijuana Times Show https://www.marijuanatimes.org/majority-of-americans-want-feds-to-leave-state-legal-marijuana-businesses-alone/ https://www.washingtonpost.com/opinions/it-is-too-late-to-dismantle-the-marijuana-industry/2018/01/12/42e7ccd2-f700-11e7-b34a-b85626af34ef_story.html http://www.laweekly.com/news/first-cannabis-licenses-issued-by-los-angeles-9061882 Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

New Jersey Governor is Following Through on Promises of Legalization

Last November, voters in New Jersey decided to make a big change for their state when they elected Phil Murphy as their new governor. Where their previous governor, Chris Christie, was a die-hard prohibitionist, Murphy has expressed an interest in legalizing cannabis within the state – and made sure that voters knew that he was holding to his word by reminding everyone of that fact shortly after he was inaugurated. “A stronger and fairer New Jersey embraces criminal justice reform comprehensively, and that includes a process to legalize marijuana,” Gov. Phil Murphy said shortly after taking the oath of...

Read More

01-17-2018 Video News – The Marijuana Times

Joe Klare discusses medical marijuana on the ballot in Oklahoma, how law enforcement outfits in Massachusetts view a possible crackdown and NFL stars talking about medical marijuana. 01-17-2018 – Ep. 53 | Marijuana Times Show http://www.fox23.com/news/new-poll-finds-62-of-oklahomans-support-medical-marijuana-measure/682525851 http://www.bostonherald.com/news/local_coverage/2018/01/staties_bpd_to_feds_we_won_t_bust_bud_in_bay_state https://www.youtube.com/watch?v=oCRRG0GnXpk Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

Majority of Americans Want Feds to Leave State-Legal Marijuana Businesses Alone

A new poll from YouGov and The Huffington Post shows that the majority of respondents want the federal government to leave marijuana businesses alone in states where such activities have been made legal. Some 56% say they are opposed to the feds getting involved in cannabis sales in states where they are legal, with 44% of respondents being “strongly opposed” to such efforts. On the flip side, only 30% say they support the feds cracking down, with only 18% showing strong support. There has been a lot of reaction to the announcement by U.S. Attorney General Jeff Sessions earlier...

Read More

Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100

SHARE THIS POST Treatment of pediatric ulcerative colitis will be pursued using targeted cannabinoid therapy that avoids drug psychoactivity LOS ANGELES, CA – ( January 17, 2018) — Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to announce it has submitted an orphan drug designation request for VITA-100 to the U.S. Food & Drug Administration (FDA). Upon approval, VITA-100 would be designated as an orphan drug for the treatment of pediatric ulcerative colitis (UC), a form of pediatric inflammatory bowel disease. The U.S. Orphan Drug Act (ODA) of January 1983 is meant to encourage development of drugs for rare diseases, and review by the FDA’s Office of Orphan Products Development can expedite the evaluation and eventual market approval of products that demonstrate significant promise for the treatment of these conditions. Vitality Biopharma’s gut-targeted cannabosides enable delivery of THC without psychoactivity or intoxication, which may enable more widespread use of cannabinoids for treatment of pediatric digestive disorders. The Company has already completed studies that demonstrate the efficacy of cannabosides for treatment of preclinical models of colitis. Cannabosides were able to reduce weight loss, decrease damage to the colon, and markedly improve gastrointestinal health compared to the placebo controls. “In young children,...

Read More